ArticleFrontiers in medicine2025
Integrated analysis of single-cell and bulk transcriptomic data reveals altered cellular composition and predictive cell types in ectopic endometriosis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrating Metabolic and MicroRNA Profiling to the Diagnostics of Endometriosis: A Pilot Study.International journal of molecular sciences · 2026Article
- Metabolic-epigenetic imprinting of macrophages in endometriosis: a working model for lesion persistence and treatment.Frontiers in immunology · 2026Review
- Re-Analysis of Public Transcriptomes Identifies a Candidate Histone-Cluster Signal in Eutopic Endometrium: A Hypothesis-Generating Link to Chronic Pelvic Pain.Journal of pain research · 2026Article
- ILViT: An Inception-Linear Attention-Based Lightweight Vision Transformer for Microscopic Cell Classification.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endometriosis is often diagnosed late and presents significant challenges in clinical treatment. A comprehensive investigation of the cellular classification and composition of endometriosis is essential for studying its diagnosis and treatment. Methods: This study utilized the Gene Expression Omnibus (GEO) public database and referenced single-cell RNA sequencing (scRNA-seq) atlases. The CIBERSORTx algorithm was applied to perform deconvolution on the samples and estimate the proportions of endometrial cell subtypes. A random forest model was constructed to predict the diagnosis of endometriosis. Additionally, immunohistochemical validation was performed on the marker genes of MUC5B+ epithelial cells and dStromal late mesenchymal cells, which showed high diagnostic contribution. Results: Endometriosis consists of 5 major cell types, further classified into 52 distinct cell subtypes. Compared to healthy controls, these subtypes exhibited varying degrees of alterations, with MUC5B+ epithelial cells, dStromal late mesenchymal cells, and M2 macrophages showing an increasing trend. Enriched signaling pathways were primarily associated with epithelial-mesenchymal transition (EMT), cell migration, and inflammatory responses. A random forest model, based on cell-type proportions, has been shown to achieve excellent diagnostic performance (AUC = 0.932), with MUC5B+ epithelial cells identified as the top predictive feature. Immunohistochemical validation confirmed high expression of the marker genes Conclusion: By integrating single-cell and bulk transcriptomics, we identified MUC5B+ epithelial cells and dStromal-late mesenchymal cells as dual drivers of fibrosis and inflammation in endometriosis. Our findings revealed that MUC5B+ epithelial cells may serve as the top factor for the diagnosis of endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.